Cabozantinib D4 | CAS 1802168-53-1 - Request Quote
Cabozantinib D4
| SZ CAT No: | SZ-C112D01 |
| CAS No | 1802168-53-1 |
| Mol.F. | C28H20D4FN3O5 |
| Mol.Wt. | 505.5 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Cabozantinib D4 is chemically N-(4-((6,7-Dimethoxyquinolin-4-yl)oxy)phenyl)-N-(4-fluorophenyl-2,3,5,6-d4)cyclopropane-1,1-dicarboxamide. Cabozantinib D4 is supplied with detailed characterization data compliant with regulatory guideline. Cabozantinib D4 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Cabozantinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1802168-53-1
Purchase 1802168-53-1
Order 1802168-53-1
Enquire 1802168-53-1
price of 1802168-53-1
1802168-53-1 Supplier
1802168-53-1 Manufacturer
1802168-53-1 Exporter
buy high quality Cabozantinib D4
Purchase Cabozantinib D4
Cabozantinib D4 suppliers
Cabozantinib D4 manufacturers
Cabozantinib D4 price
Order Cabozantinib D4
Enquire Cabozantinib D4
Cabozantinib D4 cost
Cabozantinib D4 Supplier
Cabozantinib D4 Distributor
Cabozantinib D4 for Method Validation
Cabozantinib Reference Standard
Cabozantinib D4 for ANDA Filing
Cabozantinib D4 for Forced Degradation Studies
Cabozantinib D4 Identification Standards
Cabozantinib D4 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


